Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cryoballoon Isolation of Combined Posterior Wall and Pulmonary Veins Versus Pulmonary Veins Alone for the Treatment of Paroxysmal Atrial Fibrillation (IMPPROVE-PAF)

NCT05296824 is registered in ClinicalTrials.gov with Sacramento EP Research as lead sponsor.

NCT NCT05296824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05296824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cryoballoon Isolation of Combined Posterior Wall and Pulmonary Veins Versus Pulmonary Veins Alone for the Treatment of Paroxysmal Atrial Fibrillation (IMPPROVE-PAF)
Lead sponsor
Sacramento EP Research
Phase
Observational
Overall status
Completed
Start date
January 1, 2014
Completion date
December 31, 2021
Enrollment
320 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation